Lipiodol Ultra-Fluid

Ethyiodized Oil, the active ingredient in Lipiodol Ultra-Fluid, is an iodinated oil‑based contrast media presented as a liquid for intralymphatic use. It provides radiopaque contrast to enhance visualization of lymphatic structures during diagnostic and interventional procedures. GNH USA supplies Lipiodol Ultra-Fluid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lipiodol Ultra-Fluid, an iodinated oil‑based contrast agent, is used in lymphatic imaging procedures. - Lymphangiography: Enables detailed visualization of lymphatic vessels and nodes for diagnostic assessment. - Detection of lymphatic leaks: Highlights sites of lymphatic leakage to guide therapeutic intervention. - Sentinel lymph node mapping: Provides contrast to identify sentinel nodes during oncologic surgery.

Lipiodol Ultra-Fluid may cause a range of adverse reactions.

Common Side Effects: - Injection site pain: mild discomfort at the site of administration. - Nausea or vomiting: transient gastrointestinal upset. - Mild fever: low‑grade temperature elevation. - Transient hypotension: temporary drop in blood pressure.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergy requiring immediate medical intervention. - Oil embolism: blockage of vessels by oil droplets, potentially affecting lungs or brain. - Tissue necrosis: localized tissue death at the injection site. - Severe hypotension: marked blood pressure decline needing treatment. - Renal impairment: worsening kidney function in susceptible patients.

Before using Lipiodol Ultra-Fluid, consider the following precautions. - Allergy assessment: verify no known iodine or oil allergy. - Renal function: evaluate kidney status prior to administration. - Pregnancy: avoid unless the clinical benefit outweighs potential risk. - Concurrent medications: review anticoagulant or thyroid therapy that may interact. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Lipiodol Ultra-Fluid can interact with other agents.

Major Interactions (Avoid): - Iodine‑containing medications: may increase total iodine load and risk toxicity. - Thyroid hormone therapy: can alter thyroid function test results. - Radiopharmaceuticals: may interfere with nuclear imaging interpretation.

Moderate Interactions (Monitor Closely): - Nephrotoxic drugs: monitor renal function when used together. - Diuretics: may affect fluid balance and contrast distribution. - Other contrast‑enhancing agents: consider cumulative iodine exposure.